Women's Health Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
CIBO, Jalisco
Drug-resistance mutations identified in HAART-naive HIV-infected patients
February 5th, 2006
Drug-resistance mutations were identified in HAART-naive HIV-infected patients. In a recent report, researchers in Mexico conducted a study to "describe the prevalence of baseline drug-resistance mutations, resistance to antiretroviral drugs, and the subsequent virological response to therapy in treatment-naive patients from Mexico with established HIV-1 infection. "Resistance testing was performed on plasma samples from antiretroviral-naive patients. Data on mutations associated with antiretroviral drug resistance were obtained using Stanford software Ninety-six treatment-naive individuals were enrolled in the study...
Source: Women's Health Law Weekly (2006-02-05)
|
